In News

Follow this topic

Bookmark

Record learning outcomes

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the successful reclassification of Nasonex Allergy Control 0.05% Nasal Spray following a public consultation. The spray, which will soon be available over the counter in pharmacies, is used to treat symptoms of allergic rhinitis. 

The decision follows the POM to P reclassification granted to Maloff Protect last week. MHRA commented that is €committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do€.